D Liénard
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
Papers in
-
- Melanoma and MAPK Pathways 3
- vaccines and immunoinformatics approaches 3
- RNA Interference and Gene Delivery 2
- Oncology 7
- Cutaneous Melanoma Detection and Management 6
- Co-authors
- Patricia Ewalenko (4 shared papers)Ferdy J. Lejeune (5 shared papers)Nathalie Renard (1 shared paper)Donata Rimoldi (5 shared papers)Pedro Romero (3 shared papers)J C Cerottini (2 shared papers)Michael Hahne (1 shared paper)Thierry Bornand (1 shared paper)
- Journals
- Melanoma Research (2 papers)European Journal of Cancer (2 papers)Journal of Surgical Oncology (1 paper)Journal of Nuclear Medicine (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- SwitzerlandBelgiumGermany
In The Last Decade
D Liénard
21 papers receiving 2.2k citations
D Liénard's Hit Papers
Peers
Comparison fields: 5 of 88
- Immunology 1.1k
- Oncology 818
- Immunology and Allergy 99
- Cancer Research 201
- Molecular Biology 977
Countries citing papers authored by D Liénard
This map shows the geographic impact of D Liénard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Liénard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Liénard more than expected).
Fields of papers citing papers by D Liénard
This network shows the impact of papers produced by D Liénard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Liénard. The network helps show where D Liénard may publish in the future.
Co-authors
The 25 scholars most cited alongside D Liénard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape Hit paper breakdown → | 1996 | 1107 |
| 2 | High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. Hit paper breakdown → | 1992 | 622 |
| 3 | 2004 | 88 | |
| 4 | Frequent cytolytic T-cell responses to peptide MAGE-A10(254-262) in melanoma. | 2001 | 67 |
| 5 | Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376. | 1999 | 65 |
| 6 | Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients. | 1997 | 56 |
| 7 | 2008 | 39 | |
| 8 | Results of 206 isolated limb perfusions for malignant melanoma. | 1989 | 39 |
| 9 | Clinical experience with high-dose tumor necrosis factor alpha in regional therapy of advanced melanoma. | 1994 | 38 |
| 10 | Isolation limb perfusion with tumor necrosis factor alpha and chemotherapy for advanced extremity soft tissue sarcomas. | 1997 | 32 |
| 11 | Administration of high-dose tumor necrosis factor alpha by isolation perfusion of the limbs. Rationale and results. | 1995 | 23 |
| 12 | 2007 | 21 | |
| 13 | 2006 | 16 | |
| 14 | Hyperthermic isolated limb perfusion with tumor necrosis factor alone for melanoma. | 2006 | 14 |
| 15 | 1993 | 10 | |
| 16 | Assessment of the haematocrit method for dosimetry of cytostatics in isolation perfusion | 1989 | 8 |
| 17 | 2000 | 5 | |
| 18 | Physiological and pharmacokinetics parameters in isolation perfusion of the limbs. | 1994 | 3 |
| 19 | 1997 | 3 | |
| 20 | 2004 | 1 |
About D Liénard
D Liénard is a scholar working on Molecular Biology, Oncology, Immunology, Pulmonary and Respiratory Medicine and Genetics, having authored 21 papers that have together received 2.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), Cutaneous Melanoma Detection and Management (6 papers), T-cell and B-cell Immunology (5 papers), Sarcoma Diagnosis and Treatment (4 papers), Melanoma and MAPK Pathways (3 papers), vaccines and immunoinformatics approaches (3 papers), Virus-based gene therapy research (3 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Immunology (1.1k citations), Oncology (818 citations), Immunology and Allergy (99 citations), Cancer Research (201 citations) and Molecular Biology (977 citations). D Liénard has collaborated with scholars based in Switzerland, Belgium and Germany. Frequent co-authors include Patricia Ewalenko, Ferdy J. Lejeune, Nathalie Renard, Donata Rimoldi, Pedro Romero, J C Cerottini, Michael Hahne, Thierry Bornand, Pascal Schneider and Lars E. French. Their work appears in journals such as Melanoma Research, European Journal of Cancer, Journal of Surgical Oncology, Journal of Nuclear Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.